Recently, Wang et al. identified fibrinogen-like protein 1 (FGL1) as a high affinity soluble ligand for LAG-3 and reported that FGL1-LAG3 interaction critically impedes CD8+ T cell-mediated anti-tumor immunity [121]. This evidence concerns the gene CD8A and neoplasm.